230 related articles for article (PubMed ID: 23106864)
41. Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus Pyogenes.
Huish S; Thelwell C; Longstaff C
PLoS One; 2017; 12(1):e0170936. PubMed ID: 28125743
[TBL] [Abstract][Full Text] [Related]
42. Interaction of a group A Streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structures.
D'Costa SS; Boyle MD
Microb Pathog; 1998 Jun; 24(6):341-9. PubMed ID: 9632538
[TBL] [Abstract][Full Text] [Related]
43. Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen.
Wang H; Lottenberg R; Boyle MD
Microb Pathog; 1995 Mar; 18(3):153-66. PubMed ID: 7565010
[TBL] [Abstract][Full Text] [Related]
44. Inactivation of the streptokinase gene prevents Streptococcus equisimilis H46A from acquiring cell-associated plasmin activity in the presence of plasminogen.
Malke H; Mechold U; Gase K; Gerlach D
FEMS Microbiol Lett; 1994 Feb; 116(1):107-12. PubMed ID: 8132150
[TBL] [Abstract][Full Text] [Related]
45. Characterizing the role of tissue-type plasminogen activator in a mouse model of Group A streptococcal infection.
Ly D; Donahue D; Walker MJ; Ploplis VA; McArthur JD; Ranson M; Castellino FJ; Sanderson-Smith ML
Microbes Infect; 2019; 21(8-9):412-417. PubMed ID: 31009808
[TBL] [Abstract][Full Text] [Related]
46. Post-proteomic identification of a novel phage-encoded streptodornase, Sda1, in invasive M1T1 Streptococcus pyogenes.
Aziz RK; Ismail SA; Park HW; Kotb M
Mol Microbiol; 2004 Oct; 54(1):184-97. PubMed ID: 15458415
[TBL] [Abstract][Full Text] [Related]
47. Streptokinase activates plasminogen bound to human group C and G streptococci through M-like proteins.
Ben Nasr A; Wistedt A; Ringdahl U; Sjöbring U
Eur J Biochem; 1994 Jun; 222(2):267-76. PubMed ID: 8020466
[TBL] [Abstract][Full Text] [Related]
48. Analysis of plasminogen-binding M proteins of Streptococcus pyogenes.
Ringdahl U; Sjöbring U
Methods; 2000 Jun; 21(2):143-50. PubMed ID: 10816375
[TBL] [Abstract][Full Text] [Related]
49. Is plasminogen deployed as a Streptococcus pyogenes virulence factor?
Walker MJ; McArthur JD; McKay F; Ranson M
Trends Microbiol; 2005 Jul; 13(7):308-13. PubMed ID: 15936195
[TBL] [Abstract][Full Text] [Related]
50. A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci.
Wang H; Lottenberg R; Boyle MD
J Infect Dis; 1995 Jan; 171(1):85-92. PubMed ID: 7798686
[TBL] [Abstract][Full Text] [Related]
51. Interaction of group A streptococci with human plasmin(ogen) under physiological conditions.
D'Costa SS; Boyle MD
Methods; 2000 Jun; 21(2):165-77. PubMed ID: 10816378
[TBL] [Abstract][Full Text] [Related]
52. Preparation of a novel streptokinase mutant with improved stability.
Shi GY; Chang BI; Su SW; Young KC; Wu DH; Chang LC; Tsai YS; Wu HL
Thromb Haemost; 1998 May; 79(5):992-7. PubMed ID: 9609235
[TBL] [Abstract][Full Text] [Related]
53. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin).
Musser JM; Kapur V; Kanjilal S; Shah U; Musher DM; Barg NL; Johnston KH; Schlievert PM; Henrichsen J; Gerlach D
J Infect Dis; 1993 Feb; 167(2):337-46. PubMed ID: 8093623
[TBL] [Abstract][Full Text] [Related]
54. Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model.
Li Z; Ploplis VA; French EL; Boyle MD
J Infect Dis; 1999 Apr; 179(4):907-14. PubMed ID: 10068586
[TBL] [Abstract][Full Text] [Related]
55. Characterization of a novel streptokinase produced by Streptococcus equisimilis of non-human origin.
Nowicki ST; Minning-Wenz D; Johnston KH; Lottenberg R
Thromb Haemost; 1994 Oct; 72(4):595-603. PubMed ID: 7878639
[TBL] [Abstract][Full Text] [Related]
56. Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.
Nihalani D; Raghava GP; Sahni G
Protein Sci; 1997 Jun; 6(6):1284-92. PubMed ID: 9194188
[TBL] [Abstract][Full Text] [Related]
57. Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A streptococcus clinical isolate.
Miyoshi-Akiyama T; Ikebe T; Watanabe H; Uchiyama T; Kirikae T; Kawamura Y
J Infect Dis; 2006 Jun; 193(12):1677-84. PubMed ID: 16703511
[TBL] [Abstract][Full Text] [Related]
58. Preferential Acquisition and Activation of Plasminogen Glycoform II by PAM Positive Group A Streptococcal Isolates.
De Oliveira DM; Law RH; Ly D; Cook SM; Quek AJ; McArthur JD; Whisstock JC; Sanderson-Smith ML
Biochemistry; 2015 Jun; 54(25):3960-8. PubMed ID: 26029848
[TBL] [Abstract][Full Text] [Related]
59. Uncovering the mysteries of invasive streptococcal diseases.
Chhatwal GS; McMillan DJ
Trends Mol Med; 2005 Apr; 11(4):152-5. PubMed ID: 15823752
[TBL] [Abstract][Full Text] [Related]
60. Structural domains of streptokinase involved in the interaction with plasminogen.
Rodríguez P; Fuentes P; Barro M; Alvarez JG; Muñoz E; Collen D; Lijnen HR
Eur J Biochem; 1995 Apr; 229(1):83-90. PubMed ID: 7744053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
